Page last updated: 2024-10-26

disulfiram and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

disulfiram has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

Research Excerpts

ExcerptRelevanceReference
"Disulfiram (DSF) is a drug used to clinically control alcoholism that has recently been shown to be cytotoxic for multiple cancers."1.72Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin-proteasome pathway. ( Chen, C; Chen, Z; Huang, Y; Li, Y; Liu, X; Liu, Z; Nie, D; Sui, S; Tan, J; Wang, X; Yu, X; Yu, Z; Zeng, C; Zhong, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, C1
Nie, D1
Huang, Y1
Yu, X1
Chen, Z1
Zhong, M1
Liu, X1
Wang, X1
Sui, S1
Liu, Z1
Tan, J1
Yu, Z1
Li, Y1
Zeng, C1

Other Studies

1 other study available for disulfiram and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin-proteasome pathway.
    Journal of leukocyte biology, 2022, Volume: 112, Issue:4

    Topics: Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome; Disulfiram; Humans; Precursor T-Cell Lymphoblast

2022